Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · IEX Real-Time Price · USD
10.01
-0.47 (-4.48%)
At close: Jul 19, 2024, 4:00 PM
10.11
+0.10 (1.00%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $431.58 million as of July 22, 2024.
Market Cap
431.58M
Enterprise Value
72.07M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.01
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $431.58M, a decrease of -51.94%. That is a compound annual growth rate of -80.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 431.60M | -51.94% |
| Feb 8, 2024 | 898.10M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Biosciences of California | 452.11M |
| Absci | 448.94M |
| Altimmune | 445.27M |
| Nano-X Imaging | 441.43M |
| Nkarta | 437.60M |
| Taysha Gene Therapies | 430.95M |
| Aura Biosciences | 429.54M |
| Health Catalyst | 428.59M |